ArticleCritical reviews in oncology/hematology2025
Corrigendum to " IGF-1R inhibitors in cancer: A review of available evidence and future outlook" [Crit. Rev. Oncol./Hematol. 214 (2025) 104809].
Deniz Can Guven et al.PubMed ↗Publisher ↗
No numbers read from the abstract.